Post-earnings recap
Reported
Tue, Aug 7, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported better-than-expected earnings per share, which indicates strong performance in certain areas. However, the stock fell by 2.05% following the report, likely due to the lack of revenue data and guidance. Investors may be cautious as the company navigates market challenges without clear future projections.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.64 | N/A | +17.14% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on specific product lines while acknowledging broader market pressures. They did not provide detailed guidance for the upcoming quarters.
Management highlighted strong performance in key product areas.
They expressed confidence in long-term growth despite current market challenges.